What is a stock summary page? Click here for an overview.
Business Description
Biofarm SA
ISIN : ROBIOFACNOR9
Compare
Compare
Traded in other countries / regions
BIO.Romania0HTH.UK IPO Date
1996-11-19Description
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 122.26 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 2603.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.73 | |||||
| Beneish M-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9 | |||||
| 3-Year EBITDA Growth Rate | 6.7 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | 12.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.45 | |||||
| 9-Day RSI | 39.32 | |||||
| 14-Day RSI | 40.87 | |||||
| 3-1 Month Momentum % | -2.24 | |||||
| 6-1 Month Momentum % | -9.59 | |||||
| 12-1 Month Momentum % | -15.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.35 | |||||
| Quick Ratio | 3.64 | |||||
| Cash Ratio | 1.64 | |||||
| Days Inventory | 441.48 | |||||
| Days Sales Outstanding | 147.48 | |||||
| Days Payable | 313.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.61 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| 3-Year Dividend Growth Rate | 12.1 | |||||
| Forward Dividend Yield % | 4.61 | |||||
| 5-Year Yield-on-Cost % | 12.21 | |||||
| Shareholder Yield % | 4.51 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.34 | |||||
| Operating Margin % | 27.24 | |||||
| Net Margin % | 25.94 | |||||
| FCF Margin % | 8.51 | |||||
| ROE % | 16.24 | |||||
| ROA % | 14.15 | |||||
| ROIC % | 19.6 | |||||
| 3-Year ROIIC % | 8.79 | |||||
| ROC (Joel Greenblatt) % | 25.64 | |||||
| ROCE % | 17.02 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.82 | |||||
| PE Ratio without NRI | 8.82 | |||||
| Shiller PE Ratio | 11.29 | |||||
| Price-to-Owner-Earnings | 32.67 | |||||
| PEG Ratio | 1.12 | |||||
| PS Ratio | 2.3 | |||||
| PB Ratio | 1.38 | |||||
| Price-to-Tangible-Book | 1.4 | |||||
| Price-to-Free-Cash-Flow | 27.92 | |||||
| Price-to-Operating-Cash-Flow | 10.64 | |||||
| EV-to-EBIT | 6.87 | |||||
| EV-to-EBITDA | 5.65 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-FCF | 22.67 | |||||
| Price-to-GF-Value | 0.88 | |||||
| Price-to-Projected-FCF | 1.08 | |||||
| Price-to-DCF (Earnings Based) | 0.54 | |||||
| Price-to-DCF (FCF Based) | 2.39 | |||||
| Price-to-Median-PS-Value | 1.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.63 | |||||
| Price-to-Graham-Number | 0.74 | |||||
| Price-to-Net-Current-Asset-Value | 2.58 | |||||
| Price-to-Net-Cash | 13.4 | |||||
| Earnings Yield (Greenblatt) % | 14.53 | |||||
| FCF Yield % | 3.7 | |||||
| Forward Rate of Return (Yacktman) % | 9.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biofarm SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil lei) | 286.772 | ||
| EPS (TTM) (lei) | 0.076 | ||
| Beta | 0.42 | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 10.03 | ||
| 14-Day RSI | 40.87 | ||
| 14-Day ATR (lei) | 0.015387 | ||
| 20-Day SMA (lei) | 0.687 | ||
| 12-1 Month Momentum % | -15.29 | ||
| 52-Week Range (lei) | 0.66 - 0.83 | ||
| Shares Outstanding (Mil) | 985.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biofarm SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biofarm SA Stock Events
| Event | Date | Price (lei) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biofarm SA Frequently Asked Questions
What is Biofarm SA(BSE:BIO)'s stock price today?
The current price of BSE:BIO is lei0.67. The 52 week high of BSE:BIO is lei0.83 and 52 week low is lei0.66.
When is next earnings date of Biofarm SA(BSE:BIO)?
The next earnings date of Biofarm SA(BSE:BIO) is .
Does Biofarm SA(BSE:BIO) pay dividends? If so, how much?
The Dividend Yield %  of Biofarm SA(BSE:BIO) is 4.61% (As of Today), Highest Dividend Payout Ratio of Biofarm SA(BSE:BIO) was 0.58. The lowest was 0.21. And the median was 0.41. The  Forward Dividend Yield % of Biofarm SA(BSE:BIO) is 4.61%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers